We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Emergent BioSolutions signed an agreement with Novavax whereby Emergent will provide molecule-to-market contract development and manufacturing (CDMO) services to produce Novavax NanoFlu™.